Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|January 22, 2013
Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study)Jill van Aken, Lotte Heimans, Henrike Gillet-van Dongen, et al.
AJR. American Journal of Roentgenology|July 23, 2005
Contrast-enhanced MR angiography and digital subtraction angiography in living renal donors: diagnostic agreement, impact on decision making, and costsMarc C J M Kock, Jan N M Ijzermans, Karen Visser, et al.
Radiology|April 8, 2004
Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiographyRoland Bezooijen, Harrie C M van den Bosch, Alexander V Tielbeek, et al.
Rheumatology (Oxford, England)|February 18, 2015
Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatmentKirsten V C Wevers-de Boer, Lotte Heimans, Karen Visser, et al.
Arthritis Research & Therapy|February 13, 2014
Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED studyLotte Heimans, Kirsten V C Wevers-de Boer, K K Michel Koudijs, et al.
Rheumatology (Oxford, England)|February 17, 2012
Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studiesDiane van der Woude, Karen Visser, Naomi B Klarenbeek, et al.
Arthritis and Rheumatism|May 1, 2007
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trialHenrike van Dongen, Jill van Aken, Leroy R Lard, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)Kirsten Wevers-de Boer, Karen Visser, Lotte Heimans, et al.
Annals of the Rheumatic Diseases|May 17, 2025
Disease-modifying antirheumatic drug-free remission in psoriatic arthritis: is it attainable and sustainable? A large longitudinal studySelinde V J Snoeck Henkemans, Marijn Vis, Gonul Hazal Koc, et al.
Lancet (London, England)|July 25, 2022
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trialDoortje I Krijbolder, Marloes Verstappen, Bastiaan T van Dijk, et al.
Pageof 3